Labshake search

Citations for Selleck Chemicals :

1 - 2 of 2 citations for "S7781" since 2019

Citations are collected from bioRxiv only, the total number of publications could be much larger.

“The anti-angiogenic compound axitinib demonstrates low toxicity and anti-tumoral effects against medulloblastoma”

Marina Pagnuzzi-Boncompagni, et al., bioRxiv - Cancer Biology 2020

Quote: ... Sunitinib (Selleck Chemicals S7781) or a combination of etoposide (Selleck Chemicals S1225 ...

Product cited:

Sunitinib

Sunitinib is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with IC50 of 80...

Cat# S7781, SKU# S7781-10mM/1mL, 10mM/1mL, $97.00 Ask
“Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression”

Marie C. Hasselluhn, et al., bioRxiv - Cancer Biology 2023

Quote: ... Sunitinib (Selleck Chemicals, S7781), recombinant human WIF1 (R&D systems ...

Product cited:

Sunitinib

Sunitinib is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with IC50 of 80...

Cat# S7781, SKU# S7781-10mM/1mL, 10mM/1mL, $97.00 Ask

Feedback